Raremark gets £3m to enable precision medicine in rare disease

Oct 24, 2018 · uktech.news

Screen shot 2018 10 23 at 14.42.08 898x505

HealthTech company Raremark has raised £3m from investors. The round was led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.

Julie Walters, CEO and founder of Raremark, commented on the news: "Healthcare is becoming increasingly personalized, and precision medicine is enabling the right treatments to be delivered to the right patients. However, accessing credible and structured, real-w0rld patient data remains one of the most acute challenges facing drug development in rare disease."

Lennart Hergel, partner at Ananda Ventures, explained Raremark’s approach: "Raremark has built a technology platform using content algorithms to boost engagement and advanced data analytics to understand the mechanisms, symptoms and heterogeneity of rare diseases. The resulting high-quality insights will enable companies to develop more effective treatments that are tailored to patients’ profiles."

Read Complete Article

RT @StartupGrindLD: Our health is very important. Yet, government worries more about health-care than health-prevention. How can technology…

A no-deal #Brexit would harm London’s economy and it’s my job as Mayor to stand up for Londoners – we need a public… https://t.co/yvTSZ3xjLm

The London Tech Week Schools Competition is live! Open to students across the capital to help solve London's proble… https://t.co/qavFLHv7Yc

Robert Armstrong: My great-uncle was my hero — a fearless reporter who covered Mussolini and Peron's regimes. But w… https://t.co/vsotLj8gOL

Financial confusion holds back SMEs💸 https://t.co/lru1lmKbFA